Breaking News

Olon Group to Add New High Potency API Suite in Ohio

Expands its capabilities to serve clients developing innovative therapies for cancer, rare diseases and other challenging therapeutic areas.

Author Image

By: Charlie Sternberg

Associate Editor

Olon Group has announced a new GMP High Potency Active Pharmaceutical Ingredient (HPAPI) suite, which is currently under construction at the Olon USA site in Concord, Ohio, the center of excellence for early development of APIs within the Olon Group.   This expansion adds to the commercial scale expertise and capabilities of the Segrate and Rodano sites near Milan, Italy, and it is part of an important growth of capabilities for handling HPAPI in the group where the company has invested approx...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters